Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1995 Jun;113(6):725-7.
doi: 10.1001/archopht.1995.01100060051031.

A comparison of topical diclofenac with prednisolone for postcataract inflammation

Affiliations
Clinical Trial

A comparison of topical diclofenac with prednisolone for postcataract inflammation

C W Roberts et al. Arch Ophthalmol. 1995 Jun.

Abstract

Objective: To compare diclofenac sodium with prednisolone acetate for the control of postoperative inflammation after cataract surgery.

Design: Fifty-two patients undergoing phacoemulsification with posterior chamber intraocular lens implantation were randomly assigned to receive either 0.1% diclofenac eye drops or 1% prednisolone eye drops as their postoperative anti-inflammatory medication. The patients were examined 1 day (baseline), 1 week, and 1 month after surgery. Postoperative inflammation was evaluated subjectively by slit-lamp assessment of cell and flare and objectively by measurement of cell and flare with a laser cell and flare meter.

Results: At each visit, there was no statistically significant difference in postoperative inflammation either by slit-lamp assessment or with the laser cell and flare meter for the two treatment groups.

Conclusion: In the dosage used, diclofenac was as effective an anti-inflammatory agent for uncomplicated post-cataract inflammation as prednisolone.

PubMed Disclaimer

Publication types